XBiotech Inc

XBITNASDAQ • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
2.37 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
2.37
↘ 0.00 (0.21%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
2.37
↘ 0.00 (0.21%)
🔴Market: CLOSED
Open?$2.38
High?$2.38
Low?$2.35
Prev. Close?$2.37
Volume?33.2K
Avg. Volume?28.2K
VWAP?$2.36
Rel. Volume?1.18x
Bid / Ask
Bid?$2.34 × 1.2K
Ask?$2.40 × 100
Spread?$0.06
Midpoint?$2.37
Valuation & Ratios
Market Cap?72.3M
Shares Out?30.5M
Float?16.6M
Float %?54.4%
P/E Ratio?N/A
P/B Ratio?0.54
EPS?-$1.32
Dividend?0.00%
Ex-Dividend?N/A

Shares of XBiotech Inc (XBIT) are trading at $2.37. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, XBIT appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Infectious Disease & Vaccines
Employees
87
Market Cap
72.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.xbiotech.com
Listed
2015-04-15
Address
5217 WINNEBAGO LANE
AUSTIN, TX 78744
Phone: 512-386-2900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
66
Piotroski F-Score?0/9Weak
Altman Z-Score?7.41Safe
Confidence?40%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?1.11%Low
Short Interest?184.0K
Days to Cover?7.3
Free Float16.6M
Avg Daily Volume25.1K
Settlement Date2026-05-15
Financial Health
Current Ratio?39.03Strong
Quick Ratio?39.03Strong
Cash Ratio?38.50Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.54CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.9CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
6
-29.8%WEAK▾
ROA?
S&P
3
-28.7%WEAK▾
Cash Flow & Enterprise
FCF?$-42364000
Enterprise Value?$-43203078
Fundamentals ratios updated end of day
MarketsMoversWatchlist